Skip to main content
Year archive

Ensol Biosciences Inc. — 2023 filings

All 26 regulatory filings released by Ensol Biosciences Inc. (140610) in 2023, sourced directly from the official regulator.

26 Filings
2023 Period
2023 filings (26)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2023-12-15 Korean
기타주요경영사항(자율공시)(코스닥시장 상장을 위한 상장예비심사청구 철회의 건)
Regulatory Filings
2023-12-14 Korean
임상시험단계진입ㆍ종료(자율공시)(항암제 병용 치료제 카리스1000(C1K) 제1상 임상시험 종료)
Regulatory Filings
2023-11-13 Korean
기업설명회(IR)개최결과
Report Publication Announcement
2023-10-20 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-10-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-07-10 Korean
임상시험단계진입ㆍ종료(자율공시)(골관절염 치료제 엔게디1000(E1K) 제1b상 임상시험 종료)
Regulatory Filings
2023-05-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-14 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-10 Korean
주주총회소집결의
AGM Information
2023-03-08 Korean
이전상장결정
Delisting Announcement
2023-02-28 Korean
기타주요경영사항(자율공시)(코스닥시장 상장을 위한 상장예비심사 청구)
Regulatory Filings
2023-02-28 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-02-21 Korean
전환가액의조정(제1회차 CB)
Capital/Financing Update
2023-02-21 Korean
전환가액의조정(제2회차 CB)
Share Issue/Capital Change
2023-02-21 Korean
전환가액의조정(제3회차 CB)
Share Issue/Capital Change
2023-02-21 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2023-02-20 Korean
전환가액의조정(제1회차 CB)
Capital/Financing Update
2023-02-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2023-02-10 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-02-10 Korean
기타주요경영사항(자율공시)(전환우선주 전환가액 조정)
Share Issue/Capital Change
2023-01-16 Korean
전환가액의조정(제2회차 CB)
Share Issue/Capital Change
2023-01-04 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Regulatory Filings
2023-01-02 Korean